Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.5 DKK | +1.11% | +0.10% | -15.33% |
Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.33% | 1.66B | |
+25.83% | 661B | |
+26.36% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.77% | 231B | |
+5.27% | 200B | |
-8.79% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Transcript : Bavarian Nordic A/S - Analyst/Investor Day